|
Journal of Clinical Oncology, ASCO Annual Meeting Proceedings (Post-Meeting Edition).
Vol , No 18S ( Supplement), :
© 2009 American Society of Clinical Oncology
| Dose mg/m2 |
Schedule |
50% PSA Decline |
2550% PSA Decline |
Gr 23 Neuropathy |
Gr 23 Nausea |
Gr 23 Fatigue |
|
| 120 |
q2wks |
0/3 |
0/3 |
0/3 |
0/3 |
0/3 |
| 168 |
q2wks |
1/3 |
0/3 |
0/3 |
0/3 |
0/3 |
| 236 |
q2wks |
0/3 |
1/3 |
2/3 |
2/3 |
0/3 |
| 330 |
q2wks |
2/6 |
2/6 |
4/6 |
2/6 |
2/6 |
| 330 |
q3wks |
0/14 |
1/14 |
7/14 |
2/14 |
4/14 |
| 462 |
q3wks |
0/4 |
1/4 |
1/4 |
1/4 |
0/4 |
| 330 |
d 1, 15q6wks |
Ongoing
|
|
|